GUTS — FRACTYL HEALTH, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1572616 ·
Last close
$0.69
Market Cap
$108.67M
52W High
$1.03
52W Low
$0.62
ADV30
1,660,453
Next earnings
2026-08-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -20,820,000 | 9,218,000 | 99,385,000 | 63,168,000 | 78,008,000 |
| Dec 2025 | 0 | 0 | -23,284,000 | -43,727,000 | 121,402,000 | 81,540,000 | 111,944,000 |
| Sep 2025 | 0 | 0 | -22,694,000 | -45,603,000 | 114,272,000 | 77,657,000 | 117,450,000 |
| Jun 2025 | 0 | 0 | -26,079,000 | -27,889,000 | 62,006,000 | 22,291,000 | 80,218,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-87,726,000
Investing CF
$-109,000
Financing CF
$108,895,000
CapEx
$-557,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.49
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-547,046,000
Inventory
$0
Receivables
$0
ST Investments
—
EBIT TTM
$-92,877,000
Pretax Income TTM
$-108,001,000
Interest Exp TTM
—
Analysts
5
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -96,816,000 | -140,954,000 | 121,402,000 | 111,944,000 | — | -90,328,000 |
| Dec 2024 | 93,000 | -93,531,000 | -68,694,000 | 108,077,000 | 79,653,000 | — | -65,521,000 |
| Dec 2023 | 120,000 | -50,836,000 | -77,091,000 | 76,212,000 | 401,274,000 | — | -42,823,000 |
| Dec 2022 | 0 | -49,385,000 | -46,453,000 | 60,956,000 | 313,275,000 | — | -46,243,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.50
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VANI | Vivani Medical, Inc. | $110.38M | $1.28 | — |
| LAKE | LAKELAND INDUSTRIES INC | $112.51M | $11.40 | — |
| MBOT | Microbot Medical Inc. | $115.52M | $1.72 | — |
| STXS | Stereotaxis, Inc. | $125.53M | $1.26 | — |
| SKIN | SkinHealth Systems Inc. | $88.91M | $0.69 | — |
News headlines (Yahoo Finance, 1h cache)
Fractyl Health to Participate in Upcoming Investor Events
2026-07-22 20:01 · Yahoo
Fractyl Health Stock Up on Encouraging One-Year Revita Study Results
2026-07-16 14:13 · Yahoo
Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s
2026-07-15 13:02 · Yahoo
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
2026-07-15 10:00 · Yahoo
Fractyl Health (GUTS) Stock Sees Fair Value Cut As Analysts Weigh Revita Opportunity
2026-07-11 21:09 · Yahoo
Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding
2026-06-12 03:23 · Yahoo
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
2026-06-04 11:00 · Yahoo
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
2026-06-01 11:00 · Yahoo
Fractyl Health (GUTS) Is Up 14.0% After First GLP-1 Gene Therapy Trial Win And Profit Turnaround
2026-05-16 20:13 · Yahoo
A Look At Fractyl Health (GUTS) Valuation After New Gene Therapy Trial Approval And First Quarter Net Income
2026-05-14 13:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.